a Western Sydney Toxicology Service , Westmead , Australia.
b School of Medicine , Western Sydney University , Sydney , Australia.
Clin Toxicol (Phila). 2018 Jul;56(7):618-621. doi: 10.1080/15563650.2017.1408812. Epub 2017 Dec 8.
Acetylcysteine (NAC), an effective antidote for paracetamol poisoning, is commonly associated with adverse reactions. This has been postulated to be related to the rapid initial infusion rate (150 mg/kg over 1 h) of the traditional three-bag protocol. We hypothesized that a slower rate would result in fewer adverse reactions. Our institution in Western Sydney moved to a modified two-bag protocol in February 2015 - first bag: 200 mg/kg over 4 h (50 mg/kg/h) and second bag: (100 mg/kg over 16 h).
Data was extracted from our database on paracetamol overdoses treated with NAC from August 2010 to September 2016. We compared adverse reactions in patients receiving the modified two-bag protocol with a historical control (traditional three-bag regimen with initial bolus of 150 mg/kg/h).
Over the study period 1011 paracetamol poisonings presented to our toxicology service, of which 476 required NAC (three-bag = 313, two-bag = 163). Demographic characteristics of the two groups were similar. Fewer anaphylactoid reactions (itch, rash, and swelling) occurred using the two-bag regimen (14% versus 5%, p = .002), a relative reduction of 66%. Similarly, there were fewer prescriptions of anti-allergy medications in the two-bag group (11% versus 4%, p = .01). There was no difference in incidence of hepatotoxicity.
Adverse reactions to NAC were less common with the two-bag regimen. These results add to the accumulating evidence that reducing the initial NAC infusion rate reduces the risk of adverse reactions.
乙酰半胱氨酸(NAC)是对乙酰氨基酚中毒的有效解毒剂,常伴有不良反应。据推测,这与传统三联袋方案中快速初始输注率(1 小时内 150mg/kg)有关。我们假设较慢的输注速度会导致较少的不良反应。我们位于西悉尼的机构于 2015 年 2 月采用改良的两袋方案 - 第一袋:4 小时内 200mg/kg(50mg/kg/h)和第二袋:(16 小时内 100mg/kg)。
从 2010 年 8 月至 2016 年 9 月,我们从数据库中提取了接受 NAC 治疗的对乙酰氨基酚过量患者的数据。我们将接受改良两袋方案的患者与历史对照(初始 150mg/kg/h 推注的传统三联袋方案)的不良反应进行了比较。
在研究期间,我们的毒理学服务部门共收治了 1011 例对乙酰氨基酚中毒患者,其中 476 例需要 NAC(三联袋=313 例,两袋=163 例)。两组的人口统计学特征相似。使用两袋方案的过敏样反应(瘙痒、皮疹和肿胀)发生率较低(14%对 5%,p=0.002),相对减少 66%。同样,两袋组中开具抗过敏药物的处方也较少(11%对 4%,p=0.01)。肝毒性的发生率没有差异。
两袋方案中 NAC 的不良反应较不常见。这些结果增加了越来越多的证据,表明降低初始 NAC 输注率可降低不良反应的风险。